Fighting For Diverse Talent in Biopharma

In The US, Where Black Inequity Has Become A Focus, Companies Compete For Talent

 
• By David Wild
  
Generate a summary of this article
Listen to this article
Beta

In the United States, where Black inequity has become a focus of diversity efforts, biopharma companies are working hard to recruit and retain individuals from these communities. In fact, the search for such employees and leaders has become so competitive that competition for diverse talent within the industry is now "fierce," as one executive told In Vivo.   

Biopharma Companies Are Competing For Diverse Talent • Source: Shutterstock

Black inequity in the US biopharma industry is striking. The most recent US Census indicated 12.1% of the American population are Black, but according to a 2021 Biotechnology Innovation Organization (BIO) survey of roughly 30 pharma and biotech companies, most of whom are based in the US, Black employees account for only 6% of their workforce and fill only 3% of their executive positions.

However, biopharma companies are trying to remedy that situation and indeed are doing so to the extent that a welcome...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

How to create a story in Arc

 
• By Kosh Naran

Although pharmaceuticals are exempt from the US reciprocal tariff policy, for now, the escalating global trade war is already posing practical on-the-ground problems for some companies, In Vivo investigates.

Medtechs Are Fully Engaged In Climate Change: ‘They Have No Choice’

 
• By Ashley Yeo

The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.

16 Key Trends Reshaping The Future Of Medtech

 
• By Ashley Yeo

Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.

South Korea Sees Pharma Leadership Transition

 
• By Mainbayar Badarch

Leadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.  

More from ESG

Medtechs Are Fully Engaged In Climate Change: ‘They Have No Choice’

 
• By Ashley Yeo

The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.

Podcast: Navigating Challenges – The Changing Role Of Big Pharma

 
• By Lucie Ellis-Taitt

Stefan Woxström, senior vice president of AstraZeneca, Europe and Canada, discusses the growing challenges in the industry and addresses the role big pharma must adopt in resolving them.

16 Key Trends Reshaping The Future Of Medtech

 
• By Ashley Yeo

Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.